Boston, MA -- (SBWIRE) -- 10/25/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: SPROTT RESOURCE CP(OTCMKTS:SCPZF), Pfizer Inc.(NYSE:PFE), Amarin Corporation plc (ADR)(NASDAQ:AMRN), Peregrine Pharmaceuticals(NASDAQ:PPHM).
SPROTT RESOURCE CP(OTCMKTS:SCPZF) opened its shares at the price of $2.90 for the day. Its closing price was $2.84 after losing -4.02% for the day. The company traded with the total volume of 263,353 shares, while its average trading volume remained 79,191 shares.
Has SCPZF Found The Bottom and Ready To Move Up? Find Out Here
Pfizer Inc.(NYSE:PFE) percentage change surged +0.03% to close at $30.61 with the total traded volume of 25.60 million shares, and average volume of 27.00 million. The 52 week range of the stock remained $23.55 - $31.15, while its day lowest price was $30.56 and it hit its day highest price at $30.91.
Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health and Consumer Healthcare, and Nutrition.
For How Long PFE Gloss will Attract Investors? Find out via this report
Amarin Corporation plc (ADR)(NASDAQ:AMRN) started its trading session with the price of $284 and closed at $2.16 by losing -1.32%. AMRN stocks traded with total volume of 5.63 million shares, while the average trading volume remained 12.43 million shares. The beta of AMRN stands at 1.11. Day range of the stock was $2.15 -$2.24.
Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease. The Company’s product candidate is AMR101, an ultra-pure omega-3 fatty acid
Why Should Investors Buy AMRN After the Recent Fall? Just Go Here and Find Out
Peregrine Pharmaceuticals(NASDAQ:PPHM) ended its day with the loss of -0.72% and closed at the price of $1.37 after opening at $1.37. Stock traded during its last trading session with the total volume of 2.34 million shares, as compared to its average volume of 1.07 million shares.
Peregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company developing monoclonal antibodies for the treatment and diagnosis of cancer.
Will PPHM Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)